Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2008 Jul;19(7):917-26.
doi: 10.1007/s00192-007-0554-y. Epub 2008 Jan 24.

TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence

F Araco  1 , G Gravante, R Sorge, J Overton, D De Vita, F Sesti, E Piccione
Affiliations
Randomized Controlled Trial

TVT-O vs TVT: a randomized trial in patients with different degrees of urinary stress incontinence

F Araco et al. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jul.

Abstract

TVT-O and TVT were compared in patients stratified according the severity of Stress Urinary Incontinence (SUI). Those patients with intrinsic sphincter deficiencies, overactive bladders, associated prolapses, neurovegetative disorders and recurrent SUI or under rehabilitative/medical therapies were all excluded. There were 208 women included. Operating times were longer, and postoperative pain greater for TVT (p < 0.001). TVT produced longer hospitalizations in severe SUI patients (p < 0.001). After 1 year of follow-up, incontinence was cured in all mild SUI patients with both techniques, in all severe SUI patients when treated with TVT and in 66% of them when treated with TVT-O (p < 0.001). Vaginal perforations occurred during the TVT-O (p = 0.01), bladder perforations during TVT (p = NS), bladder obstructions in mild SUI patients after TVT (p < 0.001). The severity of SUI is an important parameter that influences results after TVT-O and TVT, and could be used to guide surgeons in selecting the most effective intervention.

PubMed Disclaimer

Comment in

References

    1. Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jan;19(1):97-102 - PubMed
    1. J Urol. 2004 Jul;172(1):210-4 - PubMed
    1. Prog Urol. 2001 Dec;11(6):1306-13 - PubMed
    1. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12 Suppl 2:S5-8 - PubMed
    1. Int Urogynecol J Pelvic Floor Dysfunct. 1996;7(2):81-5; discussion 85-6 - PubMed

Publication types